Systolic blood pressure and cardiovascular outcomes during treatment of hypertension

American Journal of Medicine

Volumn 126, Issue 6, 2013, Pages 501-508

  Weber, Michael A ^a   Bakris, George L ^b   Hester, Allen ^c   Weir, Matthew R ^d   Hua, Tsushung A ^c   Zappe, Dion ^c   Dahlof, Bjorn ^e   Velazquez, Eric J ^f   Pitt, Bertram ^g   Jamerson, Kenneth ^g  

^a Downstate Health Sciences University   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF MARYLAND   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Blood pressure control; Cardiovascular events; Hypertension; Renal function; Stroke

Indexed keywords

AMLODIPINE; BENAZEPRIL; CREATININE; HYDROCHLOROTHIAZIDE;

AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; FEMALE; HUMANS; HYPERTENSION; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SYSTOLE; TREATMENT OUTCOME;

EID: 84878019523     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.01.007     Document Type: Article

References (21)

1. R. Collins, R. Peto, S. MacMahon Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context Lancet 335 1990 827 838
2. S. Lewington, R. Clarke, N. Oizibash, R. Peto, R. Collins Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual date for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
3. P. Sleight, J. Redon, P. Verdecchia Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study J Hypertens 27 2009 1360 1369
4. R.M. Cooper-DeHoff, Y. Gong, E.M. Handberg Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease JAMA 304 2010 61 68
5. J.A.N. Dorresteijn, Y. van der Graaf, W. Spiering, D.E. Grobbee, M.L. Bots, F.L.J. Visseren Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease Hypertension 59 2012 14 21
6. L. Hansson, A. Zanchetti, S.G. Carruthers Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial-HOT Study Group Lancet 351 1998 1755 1762
7. A.V. Chobanian, G.L. Bakris, H.R. Black National high blood pressure education program coordinating committee: seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure Hypertension 42 2003 1206 1252
8. G. Mancia, G. De Backer, A. Dominiczak The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC); 2007 guidelines for the management for arterial hypertension J Hypertens 25 2007 1105 1187
9. G. Mancia, S. Laurent, E. Agabeti-Rosei Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force Document Blood Press 18 2009 308 347
10. W.C. Cushman, G.W. Evans, R.P. Byington Effects of intensive blood pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
11. M.A. Weber, S. Julius, S.E. Kjeldsen Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial Lancet 363 2004 2049 2051
12. K. Jamerson, M.A. Weber, G.L. Bakris Benezapril plus amlodipine or hydrochlorothiazide for hypertension in high risk patients N Engl J Med 359 2008 2417 2428
13. M.A. Weber, G.L. Bakris, B. Dahlof Baseline characteristics in the Avoiding Cardiovascular event through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk Blood Press 16 2007 13 19
14. K. Jamerson, G.L. Bakris, C.C. Wun Rationale and design of the Avoiding Cardiovascular event through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first line combination therapies in hypertension Am J Hypertens 17 2004 793 801
15. J. Redon, G. Mancia, P. Sleight Safety and efficacy of low blood pressure among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) J Am Coll Cardiol 59 2012 74 83
16. F.H. Messerli, G. Mancia, C.R. Conti Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144 2006 884 893
17. P. Ruggenenti, G. Remuzzi Dealing with renin angiotensin inhibitors, don't mind serum creatinine Am J Nephrol 36 2012 427 429
18. S. Hirsch, J. Hirsch, U. Bhatt, B.H. Rovin Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success Am J Nephrol 36 2012 430 437
19. G.L. Bakris, M. Williams, L. Dworkin Preserving renal function in adults with hypertension and diabetes: a consensus approach Am J Kidney Dis 36 2000 646 661
20. E.J. Lewis, L.J. Hunsicker, W.R. Clark Renoprotective effect of the angiotensin receptor blocker irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851 860
21. C.A. Peralta, K.C. Norris, S. Li Blood pressure components and end stage renal disease in persons with chronic kidney disease Arch Intern Med 172 2012 41 47